申请人:MERCK SHARP & DOHME LTD.
公开号:EP0323864A2
公开(公告)日:1989-07-12
Oxadiazoles of formula I
wherein one of X, Y and Z is an oxygen atom and the other two are nitrogen atoms, and the dotted circle represents aromaticity (two double bonds) thus forming a 1,3,4-oxadiazole or 1,2,4-oxadiazole nucleus; R¹ represents a non-aromatic azacyclic or azabicyclic ring system; and R² represents an optionally substituted saturated hyrocarbon group having at least three carbon atoms, or unsaturated hydrocarbon group having at least 6 carbon atoms, have particularly advantageous selective properties for use in the treatment and/or prevention of neurodegenerative diseases.
式 I 的噁二唑
其中,X、Y 和 Z 中的一个是氧原子,另外两个是氮原子,圆点代表芳香性(两个双键),从而形成 1,3,4-噁二唑或 1,2,4-噁二唑核;R¹ 代表非芳香的氮杂环或氮杂环环系;R²代表至少有三个碳原子的任选取代饱和烃基,或至少有六个碳原子的不饱和烃基,具有特别有利的选择性,可用于治疗和/或预防神经退行性疾病。